Skip to content

Test on suppression effect of postprandial blood sodium concentration.

Test on suppression effect of postprandial blood sodium concentration. - Salt reduction test

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042354
Enrollment
30
Registered
2020-11-05
Start date
2020-11-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Ingest 3 tablets of test food A * in the first test and 3 tablets of test food B * in the second test, together with salt-loaded foods. In the third test, ingest 3 tablets of salt excretion supplement

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2. Healthy Japanese who are 20 years old or more and under 65 years old. 3. From persons who meet 2, preferentially select 30 persons with higher blood sodium delta AUC values at the time of screening, excluding those with outliers.

Exclusion criteria

Exclusion criteria: 1. Persons who have chronic illness, receiving medication, have a serious disease history 2. Persons who are allergic to the test food 3. Persons who regularly use medicines, foods for specified health use, health foods, etc. that may affect the amount of salt intake 4. Persons who have a history of hospital visits for hypertension treatment 5. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 6. Persons who have a drinking habit (more than 3 days a week, 1 go or more in terms of sake per drinking day) 7. Persons who were judged as inappropriate for subjects by the principal investigator

Design outcomes

Primary

MeasureTime frame
Blood sodium delta AUC * Before ingestion, 30, 60, 90, and 120 minutes after ingestion.

Secondary

MeasureTime frame
Total protein, albumin, neutral fat, total cholesterol, HDL-cholesterol, LDL-cholesterol, AST (GOT), ALT (GPT), ALP, gamma-GTP, CPK, total bilirubin, uric acid, urea nitrogen, creatinine, sodium, Blood levels of potassium, chlorine, calcium, iron, phosphorus, magnesium, LDH, hematocrit, blood osmotic pressure, renin activity, aldosterone. * Before ingestion, 30, 60, 90, and 120 minutes after ingestion. Postprandial urinary sodium, potassium, creatinine Blood pressure before and after ingestion (systolic blood pressure, diastolic blood pressure, pulse)

Countries

Japan

Contacts

Public ContactTakamasa Masuda

Healthcare Systems Co., Ltd. Research and Development Department

masudat@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026